Skip to main content
SpringerLink
Log in

Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials

  • Original Research Article
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Abstract

Background: Most cost-effectiveness analyses conducted alongside multinational randomized clinical trials (RCT) are carried out applying the unit costs from the country of interest to trial-wide resource use items with the objective of estimating total healthcare costs by treatment group. However, this approach could confound ‘price effects’ with ‘country effects’. An alternative approach is to use multilevel modelling techniques to analyse healthcare resource use (HCRU) from the trial, and obtain country-specific total costs by applying country-specific unit costs to corresponding shrinkage estimates of differential HCRU.

Methods: To illustrate the feasibility of this approach, we analysed data from twin multinational RCTs, which enrolled approximately 2000 individuals into three treatment arms for the management of patients with chronic respiratory disease. The models were implemented using Bayesian multilevel models, to reflect the hierarchical structure of the data while controlling for co-variates at the patient and country level.

Results: This analysis showed that directly modelling the level of HCRU is a promising approach to facilitate cost-effectiveness analyses conducted alongside multinational RCTs, offering several advantages compared with the modelling of direct costs.

Conclusions: It is argued that modelling the level of HCRU within the Bayesian framework avoids confounding the price effects with the country effects and facilitates the estimation of costs for several countries represented in the trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Table I
Table II
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Sculpher MJ, Claxton K, Drummond M, et al. Whither trial-based economic evaluation for health care decision making? Health Econ 2006; 15: 677–87

    Article  PubMed  Google Scholar 

  2. Sculpher MJ, Pang FS, Manca A, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess 2004; 8: iii–192

    CAS  Google Scholar 

  3. Manca A, Willan AR. ‘Lost in translation’: accounting for between-country differences in the analysis of multinational cost-effectiveness data. Pharmacoeconomics 2006; 24 (11): 1101–19

    Article  PubMed  Google Scholar 

  4. Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005; 21: 165–71

    PubMed  Google Scholar 

  5. Willan AR, Kowgier ME. Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate. Health Econ 2008; 17: 777–91

    Article  PubMed  Google Scholar 

  6. Manca A, Rice N, Sculpher MJ, et al. Assessing generalisability by location in trial-based cost-effectiveness analysis: the use of multilevel models. Health Econ 2005; 14: 471–85

    Article  PubMed  Google Scholar 

  7. Grieve R, Nixon R, Thompson SG, et al. Using multilevel models for assessing the variability of multinational resource use and cost data. Health Econ 2005; 14: 185–96

    Article  PubMed  Google Scholar 

  8. Grieve R, Nixon R, Thompson SG, et al. Multilevel models for estimating incremental net benefits in multinational studies. Health Econ 2007; 16: 815–26

    Article  PubMed  Google Scholar 

  9. Nixon RM, Thompson SG. Methods for incorporating covariate adjustment, subgroup analysis and betweencentre differences into cost-effectiveness evaluations. Health Econ 2005; 14: 1217–29

    Article  PubMed  Google Scholar 

  10. Willke RJ, Glick HA, Polsky D, et al. Estimating countryspecific cost-effectiveness from multinational clinical trials. Health Econ 1998; 7: 481–93

    Article  PubMed  CAS  Google Scholar 

  11. Wordsworth S, Ludbrook A. Comparing costing results in across country economic evaluations: the use of technology specific purchasing power parities. Health Econ 2005; 14: 93–9

    Article  PubMed  Google Scholar 

  12. Jonsson B, Weinstein MC. Economic evaluation alongside multinational clinical trials: study considerations for GUSTO IIb. Int J Technol Assess Health Care 1997; 13: 49–58

    Article  PubMed  CAS  Google Scholar 

  13. Thompson SG, Nixon RM, Grieve R. Addressing the issues that arise in analysing multicentre cost data, with application to a multinational study. J Health Econ 2006; 25: 1015–28

    Article  PubMed  Google Scholar 

  14. Cameron AC, Trivedi PK. Regression analysis of count data. New York: Cambridge University Press, 1998

    Book  Google Scholar 

  15. McCullagh P, Nelder J. Generalized linear models, 2nd ed. [monographs on statistics and applied probability]. New York: Chapman and Hall, 1989

    Google Scholar 

  16. Metcalfe C, Thompson SG. The importance of varying the event generation process in simulation studies of statistical methods for recurrent events. Stat Med 2006; 25: 165–79

    Article  PubMed  Google Scholar 

  17. Gelman A, Carlin J, Stern H, et al. Bayesian data analysis. New York: Chapman and Hall/CRC, 2004

    Google Scholar 

  18. Glick H, Doshi JA, Sonnad SS, et al. Economic evaluation in clinical trials. Oxford: Oxford University Press, 2007

    Google Scholar 

  19. Ohlssen DI, Sharples LD, Spiegelhalter DJ. Flexible random-effects models using Bayesian semi-parametric models: applications to institutional comparisons. Stat Med 2007; 26: 2088–112

    Article  PubMed  CAS  Google Scholar 

  20. Ghosh S, Mukhopadhyay P, Lu J. Bayesian analysis of zero inflated regression models. J Stat Planning Infer 2006; 136: 1360–75

    Article  Google Scholar 

  21. Spiegelhalter D, Thomas A, Best N, et al. Win BUGS user manual: version 1.4. Cambridge: MRC Biostatistics Unit, 2003

    Google Scholar 

  22. Getzen TE. Aggregation and themeasurement of health care costs. Health Serv Res 2006; 41: 1938–54

    Article  PubMed  Google Scholar 

  23. Rubin D. Multiple imputation for nonresponse in surveys, New York. New York: John Wiley & Sons, 1987

    Book  Google Scholar 

  24. Schafer J. Analysis of incomplete multivariate data. New York: Chapman and Hall, 1997

    Book  Google Scholar 

  25. Martin A. Bayesian inference for heterogeneous event counts. Sociol Methods Res 2003; 31: 30–63

    Article  Google Scholar 

  26. Spiegelhalter D, Best N, Carlin B, et al. Bayesian measures of model complexity and fit: series B (statistical methodology). J R Stat Soc 2002; 64: 583–639

    Article  Google Scholar 

  27. Petrinco M, Pagano E, Desideri A, et al. Information on center characteristics as costs’ determinants in multicenter clinical trials: is modeling center effect worth the effort? Value Health 2008; 12 (2): 325–30

    Article  PubMed  Google Scholar 

  28. Spiegelhalter D, Abrams K, Miles J. Bayesian approaches to clinical trials and health care evaluation. Hoboken (NJ): John Wiley & Sons, 2004

    Google Scholar 

  29. Sangho M, Jaeun S. Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis. BMC Public Health 2006 1988; 6: 88

    Article  Google Scholar 

  30. Nixon RM, Thompson SG. Parametric modelling of cost data in medical studies. Stat Med 2004; 23: 1311–31

    Article  PubMed  CAS  Google Scholar 

  31. Briggs A, Nixon R, Dixon S, et al. Parametric modelling of cost data: some simulation evidence. Health Econ 2005; 14: 421–8

    Article  PubMed  Google Scholar 

  32. Conti S, Manca A, Lambert P, et al. Bayesian multivariate modelling of patient level healthcare resource use data in RCTs [abstract]. International Health Economics Association (iHEA); 2007 Jul 9; Copenhagen

    Google Scholar 

  33. Lambert PC, Billingham LJ, Cooper NJ, et al. Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach. Health Econ 2008; 17: 67–81

    Article  PubMed  Google Scholar 

  34. Moerbeek M. The consequence of ignoring a level of nesting in multilevel analysis. Multivar Behav Res 2004; 39: 149

    Article  Google Scholar 

  35. Wennberg J, Gittelsohn J. Small area variations in health care delivery. Science 1973; 182: 1102–8

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was sponsored by Boehringer Ingelheim International GmbH and conducted by i3 Innovus under contract. Andrea Manca acted as a consultant to i3 Innovus and provided advice on the analysis of the data, the development of the models and the draft of the manuscript. The authors have no conflicts of interest that are directly relevant to this study.

Author information

Authors and Affiliations

  1. i3 Innovus, Uxbridge, UK

    Aline Gauthier

  2. Centre for Health Economics, University of York, York, UK

    Andrea Manca

  3. Boehringer-Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut, USA

    Susan Anton

Authors
  1. Aline Gauthier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Manca
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan Anton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aline Gauthier.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gauthier, A., Manca, A. & Anton, S. Bayesian Modelling of Healthcare Resource Use in Multinational Randomized Clinical Trials. Pharmacoeconomics 27, 1017–1029 (2009). https://doi.org/10.2165/11314030-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11314030-000000000-00000

Keywords

Search

Navigation